Wenjun Wu

469 total citations
30 papers, 324 citations indexed

About

Wenjun Wu is a scholar working on Complementary and alternative medicine, Molecular Biology and Oncology. According to data from OpenAlex, Wenjun Wu has authored 30 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Complementary and alternative medicine, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Wenjun Wu's work include Natural Compounds in Disease Treatment (10 papers), Natural product bioactivities and synthesis (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Wenjun Wu is often cited by papers focused on Natural Compounds in Disease Treatment (10 papers), Natural product bioactivities and synthesis (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). Wenjun Wu collaborates with scholars based in China, Taiwan and United States. Wenjun Wu's co-authors include Shun‐Fa Yang, Zhiqin Ji, Shaopeng Wei, Jue‐Liang Hsu, Chen-Hsing Chou, Hung‐Jen Liu, Shun‐Long Weng, Chi‐I Chang, Yi‐Hsuan Hsiao and Po-Hui Wang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

In The Last Decade

Wenjun Wu

27 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjun Wu China 12 167 61 59 55 54 30 324
Ganchimeg Ishdorj Canada 13 250 1.5× 81 1.3× 67 1.1× 44 0.8× 55 1.0× 16 418
Rebecca P. Danam United States 6 267 1.6× 49 0.8× 85 1.4× 63 1.1× 57 1.1× 8 409
Roberta R. Ruela-de-Sousa Brazil 11 382 2.3× 99 1.6× 50 0.8× 38 0.7× 29 0.5× 12 556
Emily A. Smith United States 9 142 0.9× 72 1.2× 28 0.5× 163 3.0× 26 0.5× 28 460
Bingqian Xie China 11 239 1.4× 73 1.2× 71 1.2× 59 1.1× 25 0.5× 16 381
Sonal M. Manohar India 13 237 1.4× 157 2.6× 74 1.3× 36 0.7× 24 0.4× 29 490
Shan‐Liang Sun China 13 311 1.9× 117 1.9× 69 1.2× 23 0.4× 40 0.7× 37 465
Pantipa Subhasitanont Thailand 13 289 1.7× 92 1.5× 75 1.3× 28 0.5× 14 0.3× 18 531
Naif A. Al-Jomah Saudi Arabia 10 372 2.2× 164 2.7× 124 2.1× 172 3.1× 78 1.4× 14 641
Christine Basmadjian France 10 417 2.5× 106 1.7× 43 0.7× 27 0.5× 17 0.3× 11 588

Countries citing papers authored by Wenjun Wu

Since Specialization
Citations

This map shows the geographic impact of Wenjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Wu more than expected).

Fields of papers citing papers by Wenjun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Wu. The network helps show where Wenjun Wu may publish in the future.

Co-authorship network of co-authors of Wenjun Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Wu. A scholar is included among the top collaborators of Wenjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Wu. Wenjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Guangyao, et al.. (2025). Synthesis and insecticidal activity evaluation of sulfonamide derivatives oriented by atom replacement strategy. SHILAP Revista de lepidopterología. 5(1). 49–57. 1 indexed citations
2.
Wu, Wenjun, et al.. (2025). Insights into pyrolysis and oxidation of 1,3-dioxane: Experimental and kinetic modeling study. Journal of Analytical and Applied Pyrolysis. 191. 107174–107174.
4.
Yang, Wei, Wei Guo, Wenjun Wu, et al.. (2025). Accuracy and cost comparison of 3D-printed guides in complex spinal deformity correction: direct vs indirect design. Frontiers in Bioengineering and Biotechnology. 13. 1611998–1611998. 1 indexed citations
5.
Hu, Yingkun, et al.. (2024). In-Depth Structural Simplification of Celangulin V: Design, Synthesis, and Biological Activity. Journal of Agricultural and Food Chemistry. 72(27). 15142–15150. 1 indexed citations
6.
Li, Xia, Liping Zhou, Xinyi Xu, et al.. (2024). Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023. Frontiers in Pharmacology. 15. 1392241–1392241. 5 indexed citations
7.
Lei, Na, Ling Zeng, Xue Li, et al.. (2023). Genetic predisposition to subjective well-being, depression, and suicide in relation to COVID-19 susceptibility and severity. Journal of Affective Disorders. 335. 233–238. 2 indexed citations
8.
Wu, Peijie, Ling Qiao, Han Yu, et al.. (2021). Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation. Frontiers in Cell and Developmental Biology. 9. 758632–758632. 15 indexed citations
9.
Lu, Pin, Shengchun Wang, Carrie A. Franzen, et al.. (2021). Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer Journal. 11(2). 39–39. 30 indexed citations
10.
Chiu, Ling‐Yen, I‐Lun Hsin, Jen‐Ning Tsai, et al.. (2020). Combination treatment of Src inhibitor Saracatinib with GMI, a Ganoderma microsporum immunomodulatory protein, induce synthetic lethality via autophagy and apoptosis in lung cancer cells. Journal of Cellular Physiology. 236(2). 1148–1157. 13 indexed citations
11.
Ming, Mei, Wenjun Wu, Bingqing Xie, et al.. (2018). XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Molecular Cancer Therapeutics. 17(12). 2564–2574. 36 indexed citations
12.
Huang, Chun‐Yao, et al.. (2018). Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan. Journal of Cancer. 9(14). 2518–2524. 14 indexed citations
13.
Weng, Shun‐Long, et al.. (2018). Significant association of long non-coding RNAs HOTAIR genetic polymorphisms with cancer recurrence and patient survival in patients with uterine cervical cancer. International Journal of Medical Sciences. 15(12). 1312–1319. 34 indexed citations
14.
Hsieh, Ming‐Ju, Wenjun Wu, Ying‐Erh Chou, et al.. (2016). Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer. International Journal of Medical Sciences. 13(12). 929–935. 9 indexed citations
15.
Ji, Zhiqin, et al.. (2012). Isolation and Characterization of Two Novel Antibacterial Cyclic Hexapeptides from Streptomyces alboflavus 313. Chemistry & Biodiversity. 9(8). 1567–1578. 13 indexed citations
16.
Cheng, Ching‐Yuan, Shur‐Hueih Cherng, Wenjun Wu, et al.. (2011). Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells. Cancer Chemotherapy and Pharmacology. 69(1). 145–154. 17 indexed citations
17.
Hsu, Jue‐Liang, et al.. (2010). Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways. European Journal of Pharmacology. 650(1). 120–129. 35 indexed citations
18.
Wei, Shaopeng, et al.. (2010). Two New Sesquiterpene Polyol Esters from Celastrus angulatus. Helvetica Chimica Acta. 93(9). 1844–1850. 6 indexed citations
19.
Wei, Shaopeng, et al.. (2009). Three Novel Sesquiterpene Esters from Celastrus Angulatus. Natural Product Communications. 4(4). 461–6. 16 indexed citations
20.
Lü, Min, Wenjun Wu, & Huixia Liu. (2007). Effect of celangulin V on detoxification enzymes in Mythimna separata and Agrotis ypsilon. Pesticide Biochemistry and Physiology. 90(2). 114–118. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026